Jade Biosciences, Inc.
JBIO
$13.97
-$0.28-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 336.16M | 198.91M | 220.94M | 49.93M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 12.66M | 2.46M | 2.04M | 775.00K | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 348.82M | 201.36M | 222.98M | 50.70M | |
|
|
|||||
| Total Current Assets | 348.82M | 201.36M | 222.98M | 50.70M | |
| Net Property, Plant & Equipment | 896.00K | 916.00K | 924.00K | 765.00K | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 69.00K | 174.00K | 60.00K | 4.86M | |
| Total Assets | 349.78M | 202.45M | 223.97M | 56.32M | |
|
|
|||||
| Total Accounts Payable | 2.15M | 1.23M | 7.59M | 4.22M | |
| Total Accrued Expenses | 14.39M | 16.06M | 10.47M | 9.79M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | 120.00K | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | 4.95M | 3.56M | 2.04M | |
| Total Other Current Liabilities | -- | 4.95M | 3.56M | 2.04M | |
| Total Current Liabilities | 16.54M | 22.36M | 21.62M | 16.05M | |
|
|
|||||
| Total Current Liabilities | 16.54M | 22.36M | 21.62M | 16.05M | |
| Long-Term Debt | -- | -- | -- | 123.00M | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 724.00K | 747.00K | 792.00K | 783.00K | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 17.26M | 23.10M | 22.41M | 139.83M | |
|
|
|||||
| Common Stock & APIC | 506.78M | 321.77M | 318.86M | 1.64M | |
| Retained Earnings | -174.39M | -142.46M | -117.28M | -85.15M | |
| Treasury Stock & Other | 129.00K | 29.00K | -24.00K | -- | |
| Total Common Equity | 332.52M | 179.35M | 201.56M | -83.51M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 2.00K | -- | -- | 2.00K | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 2.00K | -- | -- | 2.00K | |
|
|
|||||
| Total Common Equity | 332.52M | 179.35M | 201.56M | -83.51M | |
| Total Preferred Equity | 2.00K | -- | -- | 2.00K | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 332.52M | 179.35M | 201.56M | -83.51M | |
|
|
|||||